ORIC Pharmaceuticals Inc.

NASDAQ: ORIC · Real-Time Price · USD
9.80
-0.10 (-1.01%)
At close: Aug 19, 2025, 9:44 AM

ORIC Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-127.85M -100.7M -89.12M -78.72M
Depreciation & Amortization
1.11M 1.03M 966K 897K
Stock-Based Compensation
20.21M 15.23M 14.46M 12.85M
Other Working Capital
143K 1.62M 1.03M 1.14M
Other Non-Cash Items
-8.1M -6.15M -1M 1.35M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.97M 4.9M -445K 4.07M
Operating Cash Flow
-112.66M -85.69M -75.14M -59.54M
Capital Expenditures
-1.19M -849K -2.08M -939K
Cash Acquisitions
n/a n/a 2.08M 1.38M
Purchase of Investments
-251.92M -239.24M -238.12M -69.63M
Sales Maturities Of Investments
275.25M 196.69M 130.95M 229M
Other Investing Acitivies
n/a n/a -2.08M -1.38M
Investing Cash Flow
22.14M -43.4M -109.25M 158.44M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.55M -227K 225K -866K
Financial Cash Flow
126.55M 85.66M 25.23M 49.13M
Net Cash Flow
36.02M -43.43M -159.17M 148.03M
Free Cash Flow
-113.85M -86.54M -77.22M -60.48M